Elanco Animal Health Incorporated

NYSE:ELAN

13.9 (USD) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Operating Activities:
Net Income 67-8364-5032-141-1,096-97103-55-49-2248-97-104-210-61-322.8-135-53.2-49.1-9.51035.931.516.460.2-62.872.7-161.5-20.7-64.25-64.25
Depreciation & Amortization 161164170162166171173177173168167171176174170170202222.2132.380.981.583.478.769.383.173.772.775.374.387.175.278.0578.05
Deferred Income Tax 00000-531,047-32-214-29-11-35-5-82-3235-81.4-53.3-25.1-14.8-25.42416.3-73.31.813.2-2.4-6.4-6.400
Stock Based Compensation 15151514111510912151317141817161516.611.78.311.112.714.814.27.75.86.96.46.96.36.26.256.25
Change In Working Capital -2375615522-17714627-34-439-78-15-38-331156-53-7-183-125.285.2215.5-9.839.3-61.8-77.6-127.654.214.97.6-105.910.822.510.110.1
Accounts Receivables 00000-4000014000-2500014000-172.400048.400048.4000
Change In Inventory 00000-160000-26900027000-94000-33.1000-39000-39000
Change In Accounts Payables 00000200000-98000-120000369.3000-29.2000-8.40000000
Other Working Capital -2375615522-17714627-34-439275-15-38-331274-53-7-183-414.585.2215.5-9.8274-61.8-77.6-127.653.214.97.6-105.910.822.510.110.1
Other Non Cash Items -10-50-54252313193794-1669213427642628181.3-124.5-38.9-4.315.223.3-13.2-5.462.77.497.21.470.4-0.315.1515.15
Operating Cash Flow -4177162200215719861-14513189312-622238914922-92.9-111.7159.34.3126.339.652.65.6139.5163.9136.9476.776.545.345.3
Investing Activities:
Investments In Property Plant And Equipment -65-47-42-34-24-41-33-42-38-79-46-33-26-91-25-25-56-146.9-104.4-15.2-44.4-111.4-34.2-23.8-28-60.2-17.8-23.8-32.7-66.9-21.7-5-5
Acquisitions Net 7-3650-50-30-162110017-415073-5,001.3-4,56600-32.8-32.800-882.100000-441.05-441.05
Purchases Of Investments 000000000000000005,045.5000000000000000
Sales Maturities Of Investments 00000000000000000007.525.2000000000000
Other Investing Activites 0-71,28116660-1-11-2-4-317-1-8-729.4-4,592.518.3-0.469.9-48.8-25.2-0.5894.2-3.60.7-1.731.4-3.6-5.85-5.85
Investing Cash Flow -58-901,244-3337-35-36-43-55-76-37-37-29-74-441-2510-73.3-4,696.910.6-19.6-74.3-83-49-28.5-48.1-21.4-23.1-34.4-35.5-25.3-451.9-451.9
Financing Activities:
Debt Repayment 72-38-1,332-92-13-139-15637181-70-154-90-18946232-6730-17.34,169-6.5-295.3-6.1-50-57.5-7.514.82,477.7000000
Common Stock Issued 000000000000000001,219001,219.9000000000000
Common Stock Repurchased 000000000000000000000000000000000
Dividends Paid 000000000000000000000000000000000
Other Financing Activities -206-8-1-140-12-7-14-15-6-11-2-10-28-1-100.713.8-28.1-0.11.2147.2-332-377.2-2,026.8-47.2-76.5431.6405.95405.95
Financing Cash Flow 52-32-1,340-93-27-139-15739174-84-169-96-20044231-672-18.34,068.37.3896.6-6.2-48.889.7-339.5-362.4450.9-47.2-76.5431.6405.95405.95
Other Information:
Effect Of Forex Changes On Cash 29-778-3-190-3-8-132-30-14-5-8-68-2519.39.17.5-9.3-2115.92.7-14.513.620.5-93.94.6-3.63.453.45
Net Change In Cash 19-227471-7-17249-27-115-47165-296185-127659-165.2-731.2184.787224.8-76.396-376.9-257.4613.957.6-60-20.279.22.82.8
Cash At End Of Period 487468490416345352369367318345460507342638453580515505.4670.61,401.81,217.1345.1320.3396.6300.6677.5934.9321263.4323.4343.6264.42.8